Personalized eHealth Program for Life-style Change: Results From the "Do Cardiac Health Advanced New Generated Ecosystem (Do CHANGE 2)" Randomized Controlled Trial.


Journal

Psychosomatic medicine
ISSN: 1534-7796
Titre abrégé: Psychosom Med
Pays: United States
ID NLM: 0376505

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 17 3 2020
medline: 27 4 2021
entrez: 17 3 2020
Statut: ppublish

Résumé

Unhealthy life-style factors have adverse outcomes in cardiac patients. However, only a minority of patients succeed to change unhealthy habits. Personalization of interventions may result in critical improvements. The current randomized controlled trial provides a proof of concept of the personalized Do Cardiac Health Advanced New Generation Ecosystem (Do CHANGE) 2 intervention and evaluates effects on a) life-style and b) quality of life over time. Cardiac patients (n = 150; mean age = 61.97 ± 11.61 years; 28.7% women; heart failure, n = 33; coronary artery disease, n = 50; hypertension, n = 67) recruited from Spain and the Netherlands were randomized to either the "Do CHANGE 2" or "care as usual" group. The Do CHANGE 2 group received ambulatory health-behavior assessment technologies for 6 months combined with a 3-month behavioral intervention program. Linear mixed-model analysis was used to evaluate the intervention effects, and latent class analysis was used for secondary subgroup analysis. Linear mixed-model analysis showed significant intervention effects for life-style behavior (Finteraction(2,138.5) = 5.97, p = .003), with improvement of life-style behavior in the intervention group. For quality of life, no significant main effect (F(1,138.18) = .58, p = .447) or interaction effect (F(2,133.1) = 0.41, p = .67) was found. Secondary latent class analysis revealed different subgroups of patients per outcome measure. The intervention was experienced as useful and feasible. The personalized eHealth intervention resulted in significant improvements in life-style. Cardiac patients and health care providers were also willing to engage in this personalized digital behavioral intervention program. Incorporating eHealth life-style programs as part of secondary prevention would be particularly useful when taking into account which patients are most likely to benefit. https://clinicaltrials.gov/ct2/show/NCT03178305.

Identifiants

pubmed: 32176191
doi: 10.1097/PSY.0000000000000802
pii: 00006842-202005000-00009
doi:

Banques de données

ClinicalTrials.gov
['NCT03178305']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-419

Références

Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37:3232–45.
Giedrimiene D, King R. Abstract 207: Burden of Cardiovascular Disease (CVD) on Economic Cost. Comparison of outcomes in US and Europe. Circ Cardiovasc Qual Outcomes 2017;10:A207.
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O’Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation 2018;137:e67–e492.
Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 2010;121:750–8.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Van Der Worp HB, Van Dis I, Verschuren WMM, Binno S, De Backer G, Roffi M, Aboyans V, Bachl N, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GYH, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL, Achenbach S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Dean V, Erol Ç, Gaemperli O, Kolh P, Lancellotti P, Nihoyannopoulos P, Torbicki A, Carneiro AV, Metzler B, Najafov R, Stelmashok V, De Maeyer C, Dilić M, Gruev I, Miličić D, Vaverkova H, Gustafsson I, Attia I, Duishvili D, Ferrières J, Kostova N, Klimiashvili Z, Hambrecht R, Tsioufis K, Szabados E, Andersen K, Vaughan C, Zafrir B, Novo S, Davletov K, Jashari F, Kerimkulova A, Mintale I, Saade G, Petrulioniene Z, Delagardelle C, Magri CJ, Rudi V, Oukerraj L, Çölkesen BE, Schirmer H, Dos Reis RP, Gherasim D, Nedogoda S, Zavatta M, Giga V, Filipova S, Padial LR, Kiessling A, Mahdhaoui A, Ural D, Nesukay E, Gale C. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016;37:2315–81.
Kotseva K, Wood D, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Castro Conde A, Cífková R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D, EUROASPIRE Investigators. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol 2016;23:636–48.
Pagoto S, Bennett GG. How behavioral science can advance digital health. Transl Behav Med 2013;3:271–6.
Moller AC, Merchant G, Conroy DE, West R, Hekler E, Kugler KC, Michie S. Applying and advancing behavior change theories and techniques in the context of a digital health revolution: proposals for more effectively realizing untapped potential. J Behav Med 2017;40:85–98.
Latent GOLD® 5.1—Statistical Innovations. Available at: https://www.statisticalinnovations.com/latent-gold-5-1/. Accessed January 24, 2019.
Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A. Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc 2015;90:469–80.
Park LG, Beatty A, Stafford Z, Whooley MA. Mobile phone interventions for the secondary prevention of cardiovascular disease. Prog Cardiovasc Dis 2016;58:639–50.
Piette JD, Rosland AM, Marinec NS, Striplin D, Bernstein SJ, Silveira MJ. Engagement with automated patient monitoring and self-management support calls: experience with a thousand chronically ill patients. Med Care 2013;51:216–23.
Romeo A, Edney S, Plotnikoff R, Curtis R, Ryan J, Sanders I, Crozier A, Maher C. Can smartphone apps increase physical activity? Systematic review and meta-analysis. J Med Internet Res 2019;21:e12053.
Klimis H, Thakkar J, Chow CK. Breaking barriers: Mobile health interventions for cardiovascular disease. Can J Cardiol 2018;34:905–13.
Pfaeffli Dale L, Dobson R, Whittaker R, Maddison R. The effectiveness of mobile-health behaviour change interventions for cardiovascular disease self-management: a systematic review. Eur J Prev Cardiol 2016;23:801–17.
Duckworth RA. Evolution of personality: developmental constraints on Behavioral flexibility. Auk 2010;127:752–8.
Pine K, Fletcher BC. Time to shift brain channels to bring about effective changes in health behaviour. Perspect Public Health 2014;134:16–7.
Habibović M, Broers E, Piera-Jimenez J, Wetzels M, Ayoola I, Denollet J, Widdershoven J. Enhancing lifestyle change in cardiac patients through the Do CHANGE System (“Do Cardiac Health: Advanced New Generation Ecosystem”): randomized controlled trial protocol. JMIR Res Protoc 2018;7:e40.
Fletcher B, Hanson J, Page N, Pine K. FIT—Do Something Different: a new behavioral program for sustained weight loss. Psychol Swiss J Psychol 2011;70:25–34.
Walker SN, Sechrist KR, Pender NJ. Health promotion model—instruments to measure health promoting lifestyle: Health-Promoting Lifestyle Profile [HPLP II] (Adult Version). 1995; Available at: https://deepblue.lib.umich.edu/handle/2027.42/85349. Accessed July 24, 2015.
Harper A, Power M, Orley J, Herrman H, Schofield H, Murphy B, Metelko Z, Szabo S, Pibernik-Okanovic M, Quemada N, Caria A, Rajkumar S, Kumar S, Saxena S, Chandiramani K, Amir M, Bar-On D, Tazaki M, Noji A, Van Heck GN. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:S0033291798006667.
Trompenaars FJ, Masthoff ED, Van Heck GL, Hodiamont PP, De Vries J. Content validity, construct validity, and reliability of the WHOQOL-BREF in a population of Dutch adult psychiatric outpatients. Qual Life Res 2005;14:151–60.
Venkatesh V, Walton SM, Thong JYL, Xu X. Consumer acceptance and use of information ttechnology: extending the unified theory of acceptance and use of technology 1; Available at: https://pdfs.semanticscholar.org/512d/d3c7e1b55786e6f918bd0411ff744bb4cf62.pdf. Accessed June 30, 2018.
Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann 1979;2:197–207.
Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med 2005;67:89–97.
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med 2006;166:1092–7.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.
Stafford L, Berk M, Jackson HJ. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry 2007;29:417–24.
Vermunt JK, Magidson J. Technical guide for latent GOLD 5.1: basic, advanced, and syntax 1. Available at: http://www.statisticalinnovations.comhttp//www.statisticalinnovations.comorcontactusat. Accessed January 24, 2019.
Sarwar CMS, Vaduganathan M, Anker SD, Coiro S, Papadimitriou L, Saltz J, Schoenfeld ER, Clark RL, Dinh W, Kramer F, Gheorghiade M, Fonarow GC, Butler J. Mobile health applications in cardiovascular research. Int J Cardiol 2018;269:265–71.
Anker SD, Agewall S, Borggrefe M, Calvert M, Jaime Caro J, Cowie MR, Ford I, Paty JA, Riley JP, Swedberg K, Tavazzi L, Wiklund I, Kirchhof P. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J 2014;35:2001–9.
Mlakar M, Puddu PE, Somrak M, Bonfiglio S, Luštrek M, Chiron and HeartMan research projects. Mining telemonitored physiological data and patient-reported outcomes of congestive heart failure patients. PLoS One 2018;13:e0190323.
Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, Bardsley M, Steventon A, Knapp M, Henderson C, Rogers A, Sanders C, Fitzpatrick R, Barlow J, Newman SP, Whole Systems Demonstrator Evaluation Team. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ 2013;346:f653.
Duan YP, Liang W, Guo L, Wienert J, Si GY, Lippke S. Evaluation of a web-based intervention for multiple health behavior changes in patients with coronary heart disease in home-based rehabilitation: pilot randomized controlled trial. J Med Internet Res 2018;20:e12052.
Johnston N, Bodegard J, Jerström S, Åkesson J, Brorsson H, Alfredsson J, Albertsson PA, Karlsson JE, Varenhorst C. Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: a randomized study. Am Heart J 2016;178:85–94.
Karhula T, Vuorinen AL, Rääpysjärvi K, Pakanen M, Itkonen P, Tepponen M, Junno UM, Jokinen T, van Gils M, Lähteenmäki J, Kohtamäki K, Saranummi N. Telemonitoring and mobile phone-based health coaching among finnish diabetic and heart disease patients: randomized controlled trial. J Med Internet Res 2015;17:e153.
Coorey GM, Neubeck L, Mulley J, Redfern J. Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: systematic review with meta-synthesis of quantitative and qualitative data. Eur J Prev Cardiol 2018;25:505–21.
Reinwand DA, Schulz DN, Crutzen R, Kremers SP, de Vries H. Who follows eHealth interventions as recommended? A study of participants’ personal characteristics from the experimental arm of a randomized controlled trial. J Med Internet Res 2015;17:e115.
Van Roekel E, Vrijen C, Heininga VE, Masselink M, Bos EH, Oldehinkel AJ. An exploratory randomized controlled trial of personalized lifestyle advice and tandem skydives as a means to reduce anhedonia. Behav Ther 2017;48:76–96.
Saner H, van der Velde E. eHealth in cardiovascular medicine: a clinical update. Eur J Prev Cardiol 2016;23:5–12.
Schulman-Green D, Jaser S, Martin F, Alonzo A, Grey M, McCorkle R, Redeker NS, Reynolds N, Whittemore R. Processes of self-management in chronic illness. J Nurs Scholarsh 2012;44:136–44.
Astin F, Horrocks J, Closs SJ. Managing lifestyle change to reduce coronary risk: a synthesis of qualitative research on peoples’ experiences. BMC Cardiovasc Disord 2014;14:96.
McKenzie SH, Harris MF. Understanding the relationship between stress, distress and healthy lifestyle behaviour: a qualitative study of patients and general practitioners. BMC Fam Pract 2013;14:166.
Consolvo S, Mcdonald DW, Landay JA. Theory-driven design strategies for technologies that support behavior change in everyday life. Available at: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.192.9639&rep=rep1&type=pdf. Accessed April 18, 2019.
Sol BG, van der Graaf Y, van Petersen R, Visseren FL. The effect of self-efficacy on cardiovascular lifestyle. Eur J Cardiovasc Nurs 2011;10:180–6.
Nissen NK, Jónsdóttir M, Spindler H, Zwisler AO. Resistance to change: role of relationship and communal coping for coronary heart disease patients and their partners in making lifestyle changes. Scand J Public Health 2018;46:659–66.
Habibović M, Denollet J, Cuijpers P, Spek VR, van den Broek KC, Warmerdam L, van der Voort PH, Herrman JP, Bouwels L, Valk SS, Alings M, Theuns DA, Pedersen SS. E-health to manage distress in patients with an implantable cardioverter-defibrillator: primary results of the WEBCARE trial. Psychosom Med 2014;76:593–602.
Mohr DC, Cuijpers P, Lehman K. Supportive accountability: a model for providing human support to enhance adherence to eHealth interventions. J Med Internet Res 2011;13:e30.
Phillips SA, Ali M, Modrich C, Oke S, Elokda A, Laddu D, Bond S. Advances in health technology use and implementation in the era of healthy living: implications for precision medicine. Prog Cardiovasc Dis 2019;62:44–9.
Mackert M, Champlin SE, Holton A, Muñoz II, Damásio MJ. eHealth and health literacy: a research methodology review. J Comput Mediat Commu 2014;19:516–28.

Auteurs

Eva R Broers (ER)

From the Department of Medical and Clinical Psychology, Tilburg University, and Center of Research on Psychology in Somatic diseases (CoRPS) (Broers, Widdershoven, Denollet, Lodder, Kop, Habibović); Department of Cardiology (Broers, Widdershoven, Habibović), Elisabeth-TweeSteden Hospital, Tilburg; Department of Industrial Design (Wetzels, Ayoola), Eindhoven University of Technology, Eindhoven; Onmi (Ayoola), Eindhoven, the Netherlands; and Badalona Serveis Assistencials (Piera-Jimenez), Badalona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH